Written by Dr. Dixit Kumar Thakur
13+ Years Clinical Experience | Lung Infection Specialist | Delhi NCR | Pulmovista Clinics
| “If you’ve had 3 or more chest infections in a single year, it’s not bad luck — it’s a signal. It’s your body telling you that something deeper is wrong. In my 13 years at Pulmovista Clinics, I’ve seen too many patients spend years cycling through antibiotic courses, getting temporarily better, and then getting sick again — because the underlying cause was never found and treated. That pattern ends here.” — Dr. Dixit Kumar Thakur, Pulmovista Clinics, Delhi |
I am Dr. Dixit Kumar Thakur, Senior Pulmonologist at Pulmovista Clinics, Delhi. Every week, I see patients who are exhausted — not just physically, but emotionally. They have had chest infection after chest infection. They have been to general practitioners, emergency departments, and walk-in clinics. They have taken antibiotic after antibiotic. And every time they recover, they live in quiet dread of the next one — which usually arrives within weeks or months.
These patients are not unlucky. They are not ‘prone to infections’ in some vague, inexplicable way. They have an underlying condition — sometimes obvious, sometimes hidden — that is driving the recurrence. And in almost every case I see at Pulmovista Clinics, when we find that underlying condition and treat it properly, the cycle of recurrent lung infections stops.
This guide is written for every patient in Delhi who has lived through this cycle. I will explain what recurring lung infections actually signal, what hidden causes I look for at Pulmovista Clinics, why Delhi’s environment makes this worse than anywhere else in India, and what comprehensive lung infection treatment in Delhi looks like when it is done properly.
1. What Counts as ‘Recurring’ Lung Infections? Understanding the Clinical Definition
Before I explain the causes, I want to address something I see misunderstood constantly — both by patients and by some general practitioners. What exactly constitutes a ‘recurring’ lung infection, and when does it cross the line from unfortunate bad luck to a clinical pattern requiring specialist investigation?
At Pulmovista Clinics, I use the following clinical thresholds to define recurrent respiratory infections that require thorough investigation:
| Pattern | Clinical Significance |
| 3 or more chest infections in 12 months | Strongly suggests an underlying structural, immunological, or anatomical predisposing factor — requires specialist evaluation |
| 2 or more pneumonias in 12 months | Highly significant — recurrent pneumonia is almost always associated with an identifiable underlying cause |
| Same lobe repeatedly infected | A recurring infection in the same area of the lung strongly suggests a localised structural problem — foreign body, bronchial obstruction, or localised bronchiectasis |
| Infections that fail to clear fully | If X-ray shows persistent infiltrates or if cough persists more than 8 weeks after apparent recovery, the infection has not resolved — not recurred |
| Infections with unusual organisms | Fungal pneumonia, Pseudomonas, or non-tuberculous mycobacteria in an otherwise healthy adult strongly suggests immune deficiency or structural lung disease |
| Childhood history of recurrent chest infections | Patients with recurrent infections as children may have bronchiectasis, primary ciliary dyskinesia, or immune deficiency that was never formally diagnosed |
| ⚠ A Message for Patients Who Have Been Told ‘It Is Just Bad Luck’ If a healthcare provider has told you that your recurrent chest infections are simply bad luck, poor immunity, or ‘the Delhi pollution’ — without conducting a thorough investigation — please seek a specialist opinion at Pulmovista Clinics. Recurrent lung infections are almost never just bad luck. They are almost always the presenting symptom of an underlying condition that is entirely diagnosable and — in most cases — highly treatable. The danger of accepting ‘bad luck’ as an explanation is that the underlying condition progresses untreated — and conditions like bronchiectasis, undiagnosed COPD, and primary immune deficiency become significantly harder to manage with each passing year. |
2. Delhi’s Unique Role: Why This City Creates the Perfect Environment for Recurring Lung Infections
As a pulmonologist who has practiced in Delhi for over 13 years, I can tell you with absolute certainty that this city creates a uniquely hostile environment for respiratory health — one that both causes and amplifies recurrent lung infections in ways that are not fully understood by most patients, and frankly, by many general practitioners.
How Delhi’s Air Directly Causes Recurrent Infections
• PM2.5 destroys mucociliary clearance: The cilia — microscopic hair-like structures lining the airways that continuously sweep bacteria, viruses, and particles out of the lungs — are damaged and eventually paralysed by chronic PM2.5 exposure. When this natural defence system fails, pathogens that would normally be cleared are retained in the airways, causing infection.
• PM2.5 impairs alveolar macrophages: These are the immune cells that patrol the deep lung tissue and engulf pathogens. Studies consistently show that urban air pollution impairs macrophage function — reducing the lung’s first-line immune defence and increasing infection susceptibility.
• Nitrogen dioxide (NO₂) from vehicle exhaust: Delhi’s chronic NO₂ levels from 13 million+ registered vehicles damage the bronchial epithelium — the protective lining of the airways — creating entry points for bacterial and viral pathogens that would not penetrate healthy airway tissue.
• Chronic airway inflammation: Long-term pollution exposure creates persistent airway inflammation. Inflamed airways produce excess mucus, which — when not adequately cleared — becomes a culture medium for bacteria. This is why many of my recurrent infection patients at Pulmovista have chronic productive cough even between infection episodes.
• Fungal spores in Delhi’s air: Aspergillus and other fungal species thrive in Delhi’s monsoon humidity and are carried in dust storms. For patients with structural lung disease, immune deficiency, or those on corticosteroid therapy, these ubiquitous spores can cause invasive fungal infections that are frequently misdiagnosed as bacterial pneumonia.
Seasonal Patterns of Lung Infections in Delhi — What I See at Pulmovista
| Season | Dominant Infection Drivers | Most Common Presentations at Pulmovista |
| Winter (Oct–Feb) | PM2.5 inversions; cold dry air; indoor crowding; influenza; respiratory syncytial virus (RSV) | Viral bronchitis progressing to bacterial pneumonia; COPD exacerbation with infection; influenza-associated pneumonia |
| Spring (Mar–May) | Dust storms + pollen; Aspergillus spores; rising temperatures | Allergic bronchopulmonary aspergillosis (ABPA) exacerbations; recurrent bronchitis; thunderstorm-associated atypical pneumonia |
| Monsoon (Jun–Sep) | Mould explosion; Legionella from water systems; high humidity bacterial proliferation | Legionella pneumonia; recurrent Aspergillus infection; bronchiectasis infective exacerbations |
| Post-monsoon (Oct) | Stubble burning; Diwali firecrackers; rapid weather transition | Acute exacerbations of pre-existing lung disease; opportunistic infections in vulnerable patients |
3. The Hidden Causes: What I Look for When a Patient Has Recurring Lung Infections
This is the section of the guide I most want every recurrent infection patient to read carefully — because these are the conditions that are being missed. When I see a patient at Pulmovista Clinics with a history of 3 or more chest infections in a year, this is my investigative framework — the conditions I systematically rule in or out before I conclude that we have found the cause.
Hidden Cause 1: Bronchiectasis — The Most Common Missed Diagnosis
Bronchiectasis is a condition in which the bronchial tubes — the airways leading to the lungs — are permanently widened, scarred, and damaged, typically as a result of previous severe infections, whooping cough in childhood, tuberculosis, or long-term inflammation. The damaged airways cannot clear secretions effectively, creating persistent pools of mucus that become chronically infected.
Bronchiectasis is the single most common hidden cause of recurrent lung infections that I find at Pulmovista Clinics — and it is grossly underdiagnosed in India, where many patients have a history of childhood infections, TB, or whooping cough that caused airway damage that was never identified. A chest X-ray will often appear normal or near-normal in bronchiectasis — the diagnosis requires a High-Resolution CT (HRCT) of the chest.
• Classic bronchiectasis patient at Pulmovista: 45–65 year old with daily productive cough — often dismissed as ‘smoker’s cough’ even in non-smokers — 3–5 chest infections per year, frequent antibiotic courses, and a history of childhood pneumonia or TB that was ‘fully treated’ but never followed up with chest imaging.
• Treatment at Pulmovista: Airway clearance techniques (ACBT, flutter devices, oscillating PEP), regular physiotherapy, sputum culture-guided antibiotic therapy, mucolytics, bronchodilators, and — for patients with frequent infective exacerbations — consideration of long-term prophylactic azithromycin or rotating antibiotic protocols.
Hidden Cause 2: Undiagnosed or Undertreated COPD
COPD is dramatically underdiagnosed in India — with an estimated 55 million cases nationally, but a diagnosis rate below 20%. Many patients at Pulmovista Clinics with recurrent chest infections are discovered — often for the first time — to have moderate or severe COPD on spirometry. The damaged, obstructed airways of COPD impair mucociliary clearance, create mucus hypersecretion, and provide ideal conditions for bacterial colonisation and recurrent infection.
The critical point: every recurrent chest infection in a smoker, ex-smoker, or a patient with significant biomass fuel exposure or Delhi pollution exposure for 10+ years must be investigated with spirometry. A single spirometry test at Pulmovista Clinics can detect COPD that has been present and driving recurrent infections for years — and treating the COPD significantly reduces infection frequency.
Hidden Cause 3: Asthma with Recurrent Infective Exacerbations
Asthma — particularly poorly controlled, undiagnosed, or undertreated asthma — is a significant risk factor for recurrent respiratory infections. Asthmatic airways are persistently inflamed and hyper-reactive, produce excess mucus, and respond to infection triggers with severe bronchospasm that traps secretions and promotes bacterial overgrowth. Many Pulmovista patients who self-describe as ‘prone to chest infections’ are actually experiencing recurrent asthma exacerbations triggered by viral infections — a pattern known as virus-induced asthma that responds dramatically to appropriate inhaler therapy.
Hidden Cause 4: Allergic Bronchopulmonary Aspergillosis (ABPA)
ABPA is a condition in which the immune system mounts an abnormal allergic response to Aspergillus mould spores — which are abundant in Delhi’s air, particularly during and after the monsoon and in dust storm season. This allergic reaction causes recurrent episodes of bronchospasm, mucus plugging, and consolidation that are frequently misdiagnosed as bacterial pneumonia and treated with repeated antibiotic courses — with no improvement, because antibiotics have no effect on an allergic-fungal process.
ABPA is something I look for specifically at Pulmovista Clinics in every patient with recurrent ‘pneumonias’ that fail to fully clear, particularly those with asthma or a history of wheezing. The diagnosis requires specific blood tests — total IgE, Aspergillus-specific IgE, Aspergillus precipitins — and HRCT chest. Treatment involves oral corticosteroids and antifungal therapy — completely different from antibiotic-based pneumonia treatment.
Hidden Cause 5: Gastro-Oesophageal Reflux Disease (GERD) with Microaspiration
One of the most consistently overlooked causes of recurrent lung infections — particularly in patients who describe infections that predominantly affect the lower lobes, or who have more infections at night and in the early morning — is silent GERD with microaspiration. Acid from the stomach silently refluxes into the oesophagus and, in small quantities, is aspirated into the lower airways during sleep. This micro-aspiration of gastric contents creates a chronic chemical injury to the lower airway mucosa that predisposes to bacterial colonisation and recurrent pneumonia.
At Pulmovista Clinics, I routinely screen recurrent infection patients for GERD — particularly those with no other obvious predisposing factor, those with lower lobe predominance, and those who describe heartburn, regurgitation, or a chronic throat-clearing sensation. Treating GERD — with proton pump inhibitors, dietary modification, and head-of-bed elevation — frequently resolves the recurrent infection pattern without any change in respiratory therapy.
Hidden Cause 6: Primary or Secondary Immune Deficiency
Immune deficiency — either primary (inherited) or secondary (acquired) — is a critically important and frequently missed cause of recurrent lung infections. At Pulmovista Clinics, I screen for immune deficiency in any patient with 2 or more pneumonias per year, infections with unusual organisms, infections that are unusually severe or slow to resolve, or recurrent infections at multiple sites (lungs, sinuses, ears, skin) simultaneously.
| Type of Immune Deficiency | What to Look For / How I Screen at Pulmovista |
| Common Variable Immune Deficiency (CVID) | Low serum immunoglobulins (IgG, IgA, IgM) — the most common primary immune deficiency presenting in adults; recurrent bacterial infections at multiple sites |
| IgA Deficiency | Low serum IgA — the most prevalent primary immune deficiency; associated with recurrent respiratory and GI infections; often asymptomatic but clinically significant in context of recurrent infections |
| Secondary hypogammaglobulinaemia | Secondary to haematological malignancy, immunosuppressive drugs, rituximab, protein-losing conditions — screened with serum immunoglobulins |
| HIV / AIDS | CD4 count and HIV serology — opportunistic lung infections (PCP, cryptococcal pneumonia) in undiagnosed HIV are regularly missed in Delhi; low threshold for testing |
| Neutrophil dysfunction | Recurrent bacterial and fungal infections; total leucocyte count and differential; NBT test for chronic granulomatous disease |
| Complement deficiency | Recurrent encapsulated organism infections (Streptococcus pneumoniae, Haemophilus); complement levels (CH50, C3, C4) |
Hidden Cause 7: Structural Airway Abnormalities
Structural problems within or adjacent to the airways can cause recurrent infection in a specific area of the lung by creating stasis — areas where secretions pool, bacteria multiply, and infection repeatedly occurs. At Pulmovista Clinics, I investigate for:
• Endobronchial obstruction: A foreign body (inhaled object — particularly in children and elderly patients), tumour, or lymph node pressing on a bronchus from outside — causing recurrent infection distal to the obstruction. Requires bronchoscopy for diagnosis and treatment.
• Lung sequestration: A congenital malformation in which a portion of lung tissue has its own anomalous blood supply and no connection to the normal airway — creating a chronically infected, non-draining segment. Often not diagnosed until adulthood when recurrent infections prompt imaging.
• Tracheobronchomalacia: Excessive collapsibility of the large airways during breathing — impairing cough effectiveness and secretion clearance. Diagnosed by dynamic CT or bronchoscopy.
Hidden Cause 8: Primary Ciliary Dyskinesia (PCD)
Primary Ciliary Dyskinesia is a rare but important genetic condition in which the cilia lining the airways are structurally abnormal and do not beat correctly. Without effective ciliary function, the entire mucociliary clearance system — the lung’s primary defence against bacterial and viral invasion — is non-functional. Patients present with lifelong recurrent respiratory infections, chronic productive cough from childhood, and often bronchiectasis by adulthood. PCD is significantly underdiagnosed in India. At Pulmovista Clinics, I consider PCD in patients with a clear lifelong history of recurrent respiratory infections and refer for specialist nasal brushing biopsy and electron microscopy where indicated.
4. My Diagnostic Approach at Pulmovista Clinics: Finding the Hidden Cause
When a patient comes to Pulmovista Clinics with a history of recurrent lung infections, I follow a structured, systematic diagnostic protocol. This is not the approach of ordering a single test and hoping for an answer. It is a thorough, layered investigation designed to identify even the most subtle underlying predisposing condition.
| 🔬 Dr. Dixit Kumar Thakur’s Recurrent Lung Infection Investigation Protocol at Pulmovista Clinics History: Detailed infection history — frequency, severity, seasonality, organisms identified, antibiotics used, speed of recovery, history of childhood infections, TB contact/treatment, smoking, biomass exposure, occupation, travel. Clinical examination: Auscultation for basal crackles (bronchiectasis), wheeze (asthma/COPD), clubbing (bronchiectasis, ILD), nasal polyps and sinusitis (ABPA, PCD), dental hygiene (aspiration pneumonia risk). Spirometry with bronchodilator reversibility: Rules in or out COPD and asthma — the two most common hidden causes. HRCT Chest: Essential — standard chest X-ray misses bronchiectasis, early structural disease, and subtle consolidation patterns. HRCT is the cornerstone of the structural investigation. Sputum microbiology: Gram stain, culture, and sensitivity. Sputum for AFB (tuberculosis). Sputum for fungal culture and Aspergillus galactomannan. Induced sputum if spontaneous specimen unavailable. Blood tests: FBC, CRP, ESR; Serum immunoglobulins (IgG, IgA, IgM); Total IgE + Aspergillus-specific IgE + Aspergillus precipitins; HIV serology; Complement levels (CH50, C3, C4); Serum ACE (sarcoidosis); Autoimmune screen. Bronchoscopy: When endobronchial obstruction is suspected, sputum is non-diagnostic, or when BAL (bronchoalveolar lavage) is needed for microbiological sampling from the lower airways. Additional investigations as indicated: 24-hour oesophageal pH monitoring for GERD/aspiration; nasal brushing biopsy for PCD; sleep study for nocturnal aspiration; swallowing assessment for dysphagia-related aspiration. |
| “The moment I find the hidden cause — when the HRCT shows clear bronchiectasis, or the immunoglobulins come back low, or the ABPA panel is strongly positive — I feel the same thing every time. Not surprise, but relief on behalf of my patient. Because now we have an answer. And an answer means a treatment. And a treatment means the cycle can finally stop.” — Dr. Dixit Kumar Thakur, Pulmovista Clinics, Delhi |
5. Lung Infection Treatment in Delhi at Pulmovista: What Truly Comprehensive Care Looks Like
Truly comprehensive lung infection treatment in Delhi goes far beyond a course of antibiotics. At Pulmovista Clinics, once the underlying cause of recurrent infections has been identified, Dr. Dixit Kumar Thakur develops a personalised, multi-component treatment plan that addresses the infection itself, the underlying predisposing condition, and the environmental factors driving recurrence. Here is what that looks like in practice:
Treating the Acute Infection: Getting It Right the First Time
One of the most important — and most frequently neglected — aspects of lung infection management is ensuring that each acute infection is treated completely and correctly. At Pulmovista Clinics, I approach each acute infection with:
• Microbiological-guided antibiotic therapy: Culture and sensitivity results guide antibiotic selection — not empirical broad-spectrum antibiotics prescribed without knowing the organism. In recurrent infection patients, knowing the causative organism is essential for breaking the cycle.
• Adequate antibiotic duration: For bronchiectasis-associated infections, 14 days is the standard minimum — not the 5-day courses that are commonly prescribed and frequently inadequate.
• Confirmation of resolution: A chest X-ray or CT at 6–8 weeks after treatment to confirm radiological clearance. Persistent infiltrates mean the infection has not resolved — not recurred. This distinction changes the entire management approach.
• Targeted antifungal therapy for ABPA: Itraconazole or voriconazole alongside oral corticosteroids — completely different from the antibiotic approach used for bacterial pneumonia.
• Antiviral therapy where indicated: Influenza-associated pneumonia with oseltamivir (Tamiflu); COVID-associated pneumonia with nirmatrelvir-ritonavir in eligible patients.
Treating the Underlying Cause: The Key to Breaking the Cycle
| Underlying Cause | Specific Treatment at Pulmovista | Expected Outcome |
| Bronchiectasis | Airway clearance therapy (ACBT, flutter device, oscillating PEP); mucolytics; optimised bronchodilator therapy; culture-guided antibiotic courses; long-term prophylactic azithromycin for frequent exacerbators | Reduction in infection frequency; slower disease progression; improved quality of life |
| COPD | SMART therapy or LAMA+LABA; ICS for eosinophilic COPD; pulmonary rehabilitation at Pulmovista; smoking cessation; influenza and pneumococcal vaccination | Fewer exacerbations; slower lung function decline; improved exercise tolerance |
| Asthma | SMART therapy; allergen identification and avoidance; allergen immunotherapy for confirmed sensitisation; biologic therapy for severe cases | Reduction in virus-triggered exacerbations; better baseline control |
| ABPA | Oral prednisolone (tapered course); itraconazole or voriconazole for 16+ weeks; ICS; Omalizumab biologic for refractory ABPA | Prevention of lung fibrosis; reduction in infective exacerbations |
| GERD/aspiration | Proton pump inhibitor therapy; dietary and lifestyle modification; head-of-bed elevation; swallowing therapy for dysphagia; anti-reflux surgery referral for refractory cases | Resolution of recurrent lower lobe infections |
| Immune deficiency | IVIG (intravenous immunoglobulin) replacement therapy for hypogammaglobulinaemia; antiretroviral therapy for HIV; specialist haematology/immunology co-management | Dramatic reduction in infection frequency and severity |
| Structural obstruction | Bronchoscopic removal of foreign body; oncology referral for endobronchial tumour; surgical referral for sequestration or severe localised bronchiectasis | Resolution of recurrent localised infection |
Vaccination: The Most Underused Lung Infection Prevention Tool
One of the most powerful and most underused tools in recurrent lung infection prevention is vaccination. At Pulmovista Clinics, I ensure that every patient with recurrent respiratory infections is appropriately vaccinated:
• Influenza vaccine (annual): Influenza is the most common trigger for secondary bacterial pneumonia — annual vaccination is essential for all recurrent infection patients and for their household contacts.
• Pneumococcal vaccines (PCV15/PCV20 and PPSV23): Streptococcus pneumoniae is the most common cause of bacterial pneumonia in adults. Two pneumococcal vaccines — the conjugate vaccine and the polysaccharide vaccine — together provide the broadest protection and are recommended for all adults with chronic lung disease.
• COVID-19 vaccine: Updated formulations recommended for patients with chronic respiratory disease — COVID-19 pneumonia is a major cause of post-infection bronchiectasis and persistent respiratory symptoms.
• Haemophilus influenzae type b (Hib): For patients with immune deficiency — encapsulated organisms are the dominant infection risk.
6. The Role of Delhi’s Environment in Perpetuating Lung Infections — And What I Tell My Patients
I cannot change Delhi’s air. I cannot move my patients to Shimla. But I can — and do — provide every Pulmovista patient with a practical, evidence-informed environmental management plan that meaningfully reduces their exposure to the specific pollution and allergen triggers that are driving their recurrent infections. Here is exactly what I advise:
| Environmental Factor | Dr. Dixit Kumar Thakur’s Recommendation at Pulmovista |
| Indoor air quality | HEPA air purifier in the bedroom — running continuously. This single intervention reduces indoor PM2.5 by 70–90% and is the most impactful modification for patients with chronic airway disease. Check and replace filters every 6 months. |
| Outdoor exposure | Monitor SAFAR-Air or CPCB AQI daily. N95 mask (not cloth or surgical) for outdoor exposure on days with AQI >150. Avoid outdoor activity during dust storms, high-stubble-burning periods (Oct–Nov), and Diwali. |
| Aspergillus and mould | Dehumidify indoor spaces to 40–50% during monsoon — mould cannot grow below 60% humidity. Inspect bathrooms, kitchens, and AC units for visible mould monthly. Avoid composting areas, construction sites, and stored grain — all major Aspergillus sources. |
| Occupational exposures | Patients in dusty occupations (construction, agriculture, stone cutting, welding) require workplace respiratory protection (P3 respirator) and consideration of occupational lung disease assessment at Pulmovista. |
| Smoking and passive smoke | Complete elimination — non-negotiable. Even low-level passive smoke exposure significantly impairs mucociliary clearance and amplifies infection risk. At Pulmovista, every smoking patient receives formal pharmacological cessation support. |
| Indoor cooking smoke | Biomass fuel (wood, dung, crop residue) used for cooking is a major — and massively underappreciated — cause of recurrent lung infections in Delhi’s lower-income households. LPG transition, improved ventilation, and HEPA filtration are the key interventions. |
7. Airway Clearance Therapy: The Daily Habit That Prevents the Next Infection
For patients with bronchiectasis, COPD with mucus hypersecretion, or any condition that causes retained airway secretions — airway clearance therapy is one of the most important daily habits I prescribe at Pulmovista Clinics. It is also one of the most neglected, because patients often do not understand why it matters or how to do it correctly.
The principle is simple: retained mucus in damaged or obstructed airways becomes colonised with bacteria and — if not regularly cleared — becomes the source of recurrent infection. Daily airway clearance therapy keeps the airways as free of secretions as possible, dramatically reducing the bacterial load and infection risk.
Airway Clearance Techniques Taught at Pulmovista Clinics
• Active Cycle of Breathing Technique (ACBT): The gold standard airway clearance method — breathing control, thoracic expansion exercises, and forced expiration technique (huffing). Taught by the Pulmovista respiratory physiotherapy team and practiced daily at home by every bronchiectasis patient.
• Oscillating PEP devices (Flutter, Aerobika, Acapella): Handheld devices that combine positive expiratory pressure with high-frequency airway oscillation — loosening and mobilising secretions simultaneously. Particularly effective for patients with thick, tenacious sputum.
• High-Frequency Chest Wall Oscillation (HFCWO) vest: An inflatable vest that delivers rapid chest wall compressions — an alternative for patients who struggle with conventional ACBT or those with very severe secretion burden.
• Mucolytics: N-acetylcysteine or carbocisteine — prescribed to reduce mucus viscosity and make it easier to clear. Administered orally or by nebuliser depending on patient capacity and severity.
• Hypertonic saline nebulisation: Inhaled 3% or 7% hypertonic saline draws water into the airway lumen, hydrating and thinning secretions — particularly effective in bronchiectasis and cystic fibrosis. Administered before airway clearance physiotherapy for maximum effect.
8. Why Patients Across Delhi Choose Pulmovista Clinics for Lung Infection Treatment in Delhi
Patients seeking truly comprehensive lung infection treatment in Delhi choose Pulmovista Clinics because Dr. Dixit Kumar Thakur offers something that is rare in the Delhi NCR healthcare landscape: a senior pulmonologist who treats the cause of recurrent lung infections — not just the infections themselves. Here is what makes Pulmovista the right choice:
1. 13+ years of recurrent infection expertise: I have investigated and treated hundreds of patients with recurrent lung infections at Pulmovista Clinics. I know every hidden cause, every diagnostic pitfall, and every treatment pathway. Patients who have been cycling through antibiotic courses for years typically get their diagnosis at Pulmovista within 2–3 appointments.
2. Complete diagnostic infrastructure: HRCT chest, spirometry with bronchodilator reversibility, full immunological blood panel, sputum microbiology and fungal culture, bronchoscopy with BAL, ABPA panel, and 24-hour pH monitoring for GERD — all accessible through Pulmovista Clinics.
3. Microbiological precision: At Pulmovista, antibiotic prescriptions are guided by culture and sensitivity results — not broad-spectrum empirical therapy. This reduces the risk of antibiotic resistance and ensures the right antibiotic reaches the right organism at the right dose for the right duration.
4. Airway clearance therapy programme: Every bronchiectasis patient at Pulmovista receives individual airway clearance physiotherapy training — an evidence-based intervention that dramatically reduces infection frequency but is absent from most general practice management plans.
5. Vaccination and prevention: Every Pulmovista patient with chronic lung disease receives a comprehensive vaccination review — influenza, pneumococcal, COVID-19 — because prevention is the most cost-effective lung infection treatment available.
6. Environmental counselling: Delhi-specific, personalised environmental management advice is provided at every Pulmovista consultation — because no antibiotic course will prevent the next infection if the patient continues to inhale the triggers that caused it.
7. Long-term relationship: Recurrent lung infections require long-term specialist management — not one-off consultations. At Pulmovista Clinics, I build a long-term relationship with every recurrent infection patient — monitoring their condition, adjusting treatment as needed, and ensuring that the cycle of recurrence is permanently broken.
9. Frequently Asked Questions: Recurring Lung Infections and Treatment in Delhi
Q: I keep getting chest infections and my doctor just gives me antibiotics each time. What should I do?
This is exactly the situation that prompts a specialist referral to Pulmovista Clinics. If you have had 3 or more chest infections in a year and each one is being treated with antibiotics without any investigation into the underlying cause — you need a thorough specialist assessment. Repeated antibiotic courses without identifying the underlying predisposing condition not only fail to prevent future infections but also increase the risk of antibiotic resistance — making future infections harder to treat. Please book an appointment with Dr. Dixit Kumar Thakur at Pulmovista Clinics. The investigation process is straightforward and the results are almost always actionable.
Q: Is it possible to have lung infections caused by something other than bacteria?
Absolutely — and this is one of the most important points I make at Pulmovista Clinics. Lung infections in Delhi can be caused by bacteria, viruses, fungi (particularly Aspergillus), and — in some patients — mycobacteria (including tuberculosis and non-tuberculous mycobacteria). The distinction matters enormously because antibiotics are completely ineffective against fungal and viral infections, and mycobacterial infections require entirely different treatment regimens. A Pulmovista investigation — including sputum fungal culture, Aspergillus serology, and mycobacterial culture — determines the causative organism precisely, rather than assuming it is bacterial.
Q: My chest X-ray is always reported as normal between infections. Does that mean nothing is wrong?
No — and this is a source of enormous and unnecessary reassurance for patients with serious underlying conditions. Bronchiectasis — the most common hidden cause of recurrent lung infections — is frequently invisible on a plain chest X-ray and requires a High-Resolution CT (HRCT) of the chest for diagnosis. At Pulmovista Clinics, I order HRCT for every recurrent infection patient whose chest X-ray is normal but whose infection history is clinically significant. The number of hidden diagnoses we find on HRCT in patients with ‘normal’ X-rays is consistently high.
Q: Could my recurrent lung infections be related to acid reflux?
Yes — and this is one of the most frequently missed connections in clinical practice. Silent GERD with microaspiration is a real and common cause of recurrent lower lobe pneumonias, particularly in patients who sleep flat, consume alcohol regularly, or have a hiatus hernia. At Pulmovista Clinics, I screen every recurrent infection patient for GERD — particularly those with lower lobe predominance, nocturnal or early-morning infections, and those without any obvious respiratory predisposing factor. If GERD is confirmed on 24-hour pH monitoring, treating it often resolves the recurrent infection pattern completely.
Q: How many appointments will I need before a diagnosis is reached at Pulmovista Clinics?
For most recurrent infection patients, the majority of the diagnostic workup can be initiated at the first Pulmovista appointment — spirometry and blood tests same day, HRCT arranged within days. Sputum cultures, immunological results, and specialist bronchoscopy typically take 1–2 weeks to organise and report. In my clinical experience at Pulmovista, most patients have a clear underlying diagnosis established within 2–3 appointments — a timeline that contrasts sharply with the years many of them have spent receiving repeated antibiotic courses without investigation.
Conclusion: 3+ Chest Infections a Year Is Not Bad Luck — Pulmovista Clinics Can Find the Reason
After 13 years of pulmonology practice in Delhi, I have one message for every patient who has accepted recurring lung infections as their normal: you do not have to live this way. Recurrent chest infections are not inevitable, not untreatable, and not simply the price of living in Delhi. They are a clinical signal — and at Pulmovista Clinics, I have the tools, the experience, and the systematic diagnostic approach to find what that signal is pointing to.
Whether the hidden cause turns out to be bronchiectasis, COPD, asthma, ABPA, GERD, immune deficiency, or a structural airway abnormality — finding it changes everything. It changes the treatment. It changes the prognosis. And most importantly, it gives my patients something they have not had in years: the genuine possibility of staying well.
If you or someone you love has had 3 or more chest infections in the past year, please do not wait for the next one. Book a comprehensive recurrent infection assessment at Pulmovista Clinics. One thorough investigation could change the course of your respiratory health for years to come.
FAQs-Recurring Lung Infections and Treatment in Delhi
- I keep getting chest infections and my doctor just gives me antibiotics each time. What should I do?This is exactly the situation that prompts a specialist referral to Pulmovista Clinics. If you have had 3 or more chest infections in a year and each one is being treated with antibiotics without any investigation into the underlying cause — you need a thorough specialist assessment. Repeated antibiotic courses without identifying the underlying predisposing condition not only fail to prevent future infections but also increase the risk of antibiotic resistance — making future infections harder to treat. Please book an appointment with Dr. Dixit Kumar Thakur at Pulmovista Clinics. The investigation process is straightforward and the results are almost always actionable.
- Is it possible to have lung infections caused by something other than bacteria?Absolutely — and this is one of the most important points I make at Pulmovista Clinics. Lung infections in Delhi can be caused by bacteria, viruses, fungi (particularly Aspergillus), and — in some patients — mycobacteria (including tuberculosis and non-tuberculous mycobacteria). The distinction matters enormously because antibiotics are completely ineffective against fungal and viral infections, and mycobacterial infections require entirely different treatment regimens. A Pulmovista investigation — including sputum fungal culture, Aspergillus serology, and mycobacterial culture — determines the causative organism precisely, rather than assuming it is bacterial.
- My chest X-ray is always reported as normal between infections. Does that mean nothing is wrong?No — and this is a source of enormous and unnecessary reassurance for patients with serious underlying conditions. Bronchiectasis — the most common hidden cause of recurrent lung infections — is frequently invisible on a plain chest X-ray and requires a High-Resolution CT (HRCT) of the chest for diagnosis. At Pulmovista Clinics, I order HRCT for every recurrent infection patient whose chest X-ray is normal but whose infection history is clinically significant. The number of hidden diagnoses we find on HRCT in patients with 'normal' X-rays is consistently high.
- Could my recurrent lung infections be related to acid reflux?Yes — and this is one of the most frequently missed connections in clinical practice. Silent GERD with microaspiration is a real and common cause of recurrent lower lobe pneumonias, particularly in patients who sleep flat, consume alcohol regularly, or have a hiatus hernia. At Pulmovista Clinics, I screen every recurrent infection patient for GERD — particularly those with lower lobe predominance, nocturnal or early-morning infections, and those without any obvious respiratory predisposing factor. If GERD is confirmed on 24-hour pH monitoring, treating it often resolves the recurrent infection pattern completely.
- How many appointments will I need before a diagnosis is reached at Pulmovista Clinics?For most recurrent infection patients, the majority of the diagnostic workup can be initiated at the first Pulmovista appointment — spirometry and blood tests same day, HRCT arranged within days. Sputum cultures, immunological results, and specialist bronchoscopy typically take 1–2 weeks to organise and report. In my clinical experience at Pulmovista, most patients have a clear underlying diagnosis established within 2–3 appointments — a timeline that contrasts sharply with the years many of them have spent receiving repeated antibiotic courses without investigation.

